# Black Seed Sleep Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/black-seed-sleep-randomized-trial-evidence-review
Category: evidence-review
Summary: Black Seed Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are rando
Last reviewed: 2026-06-23
Reviewed by: Migaku Evidence Review
# Black Seed Sleep Randomized Trial: What the Evidence Says

## Quick Answer

Black Seed Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| A randomized controlled trial of acupoint application for postherpetic neuralgia | randomized trial | 2 | 2026-01-05 | 10.3389/fpain.2025.1637449 |
| Effects of grape seed extract supplementation on inflammatory biomarkers, oxidative stress, clinical symptoms, and quality of life in patients with migraine: A double-blinded randomized placebo-controlled clinical trial | randomized trial | 2 | 2025-01-01 | 10.4103/jrms.jrms_742_25 |

## What The Sources Report

- Acupoint application, a traditional external therapy in TCM, has shown promising results in the management of PHN, including pain relief, improved sleep quality, and enhanced quality of life. [Zhu Shizhuang (2026); evidence level 2]
- However, the available evidence is weakened by significant methodological limitations, as most trials were non-randomized, non-blinded, lacked placebo controls, and were restricted to single-center settings. [Zhu Shizhuang (2026); evidence level 2]
- Migraine symptoms have a negative impact on the patients' quality of life. 2 3 4 5 6 Although the physiopathology of migraine is not fully understood, evidence suggests that mitochondrial dysfunction followed by elevated levels of reactive oxygen species plays an important role in migraine pain. [Eshaghian Niloofar (2025); evidence level 2]
- Accordingly, previous studies have shown higher levels of oxidative stress in migraine patients than healthy individuals. In addition to oxidative stress, migraine is associated with high levels of inflammatory biomarkers such as calcitonin gene-related peptide (CGRP). [Eshaghian Niloofar (2025); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For black seed sleep randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhu Shizhuang (2026). A randomized controlled trial of acupoint application for postherpetic neuralgia. DOI: 10.3389/fpain.2025.1637449. PMCID: PMC12813113. PMID: 41561473. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12813113/
- Eshaghian Niloofar (2025). Effects of grape seed extract supplementation on inflammatory biomarkers, oxidative stress, clinical symptoms, and quality of life in patients with migraine: A double-blinded randomized placebo-controlled clinical trial. DOI: 10.4103/jrms.jrms_742_25. PMCID: PMC12860465. PMID: 41623439. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12860465/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.